Antibiotic Prophylaxis

Programas de optimización de uso de antimicrobianos (proa) en hospitales españoles: documento de consenso geih-seimc, sefh y sempsph

Medical Microbiology / Antibiotic Resistance / Hospitals / Spain / Humans / Infectious Disease / Drug Information Services / Microbial genetic and drug resistance / Antibiotic Prophylaxis / Antimicrobial resistance / Organizational Policy / Anti-Bacterial Agents / Adverse Event / Bacterial infections / Intensive Care Units / Internet / Drug Utilization / Cross-infection / Medical Audit / Inappropriate Prescribing / Infectious Disease / Drug Information Services / Microbial genetic and drug resistance / Antibiotic Prophylaxis / Antimicrobial resistance / Organizational Policy / Anti-Bacterial Agents / Adverse Event / Bacterial infections / Intensive Care Units / Internet / Drug Utilization / Cross-infection / Medical Audit / Inappropriate Prescribing

Guía de práctica clínica de la enfermedad pulmonar obstructiva crónica (EPOC) ALAT-2014: Preguntas y respuestas

Evidence Based Medicine / Humans / Smoking / Female / Male / Antibiotic Prophylaxis / Vaccination / Risk factors / Clinical Sciences / Prognosis / Chronic obstructive pulmonary disease / Combination drug therapy / Risk Factors / Epidemiologic Studies / Environmental Exposure / Randomized Controlled Trials as Topic / Antibiotic Prophylaxis / Vaccination / Risk factors / Clinical Sciences / Prognosis / Chronic obstructive pulmonary disease / Combination drug therapy / Risk Factors / Epidemiologic Studies / Environmental Exposure / Randomized Controlled Trials as Topic

Guía de práctica clínica de la enfermedad pulmonar obstructiva crónica (EPOC) ALAT-2014: Preguntas y respuestas

Evidence Based Medicine / Humans / Smoking / Female / Male / Antibiotic Prophylaxis / Vaccination / Risk factors / Clinical Sciences / Prognosis / Chronic obstructive pulmonary disease / Combination drug therapy / Risk Factors / Epidemiologic Studies / Environmental Exposure / Randomized Controlled Trials as Topic / Antibiotic Prophylaxis / Vaccination / Risk factors / Clinical Sciences / Prognosis / Chronic obstructive pulmonary disease / Combination drug therapy / Risk Factors / Epidemiologic Studies / Environmental Exposure / Randomized Controlled Trials as Topic

Cervical cerclage in twin pregnancies

Pregnancy / Humans / Female / Young Adult / Antibiotic Prophylaxis / Vagina / Anti-Bacterial Agents / Adult / Retrospective Studies / Physical examination / Pregnancy Outcome / Premature Birth / Tocolysis / Indomethacin / Vagina / Anti-Bacterial Agents / Adult / Retrospective Studies / Physical examination / Pregnancy Outcome / Premature Birth / Tocolysis / Indomethacin

Usar rifampicina más pirazinamida en profilaxis antituberculosa no incrementa el riesgo de hepatotoxicidad grave en pacientes infectados por virus de la inmunodeficiencia humana: metaanálisis de ensayos clínicos aleatorizados y controlados

Medical Microbiology / Risk / Tuberculosis / Humans / Antibiotic Prophylaxis / Hiv Infection / Human immunodeficiency virus / Enfermedades / Combination drug therapy / Isoniazid / Drug Induced Liver Injury / Pyrazinamide / Latent tuberculosis infection / Hiv Infection / Human immunodeficiency virus / Enfermedades / Combination drug therapy / Isoniazid / Drug Induced Liver Injury / Pyrazinamide / Latent tuberculosis infection

Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH

Medical Microbiology / Antibiotic Resistance / Hospitals / Spain / Humans / Infectious Disease / Drug Information Services / Microbial genetic and drug resistance / Antibiotic Prophylaxis / Antimicrobial resistance / Organizational Policy / Anti-Bacterial Agents / Adverse Event / Bacterial infections / Intensive Care Units / Internet / Drug Utilization / Cross-infection / Medical Audit / Infectious Disease / Drug Information Services / Microbial genetic and drug resistance / Antibiotic Prophylaxis / Antimicrobial resistance / Organizational Policy / Anti-Bacterial Agents / Adverse Event / Bacterial infections / Intensive Care Units / Internet / Drug Utilization / Cross-infection / Medical Audit

Programas de optimización de uso de antimicrobianos (proa) en hospitales españoles: documento de consenso geih-seimc, sefh y sempsph

Medical Microbiology / Antibiotic Resistance / Hospitals / Spain / Humans / Infectious Disease / Drug Information Services / Microbial genetic and drug resistance / Antibiotic Prophylaxis / Antimicrobial resistance / Organizational Policy / Anti-Bacterial Agents / Adverse Event / Bacterial infections / Intensive Care Units / Internet / Drug Utilization / Cross-infection / Medical Audit / Infectious Disease / Drug Information Services / Microbial genetic and drug resistance / Antibiotic Prophylaxis / Antimicrobial resistance / Organizational Policy / Anti-Bacterial Agents / Adverse Event / Bacterial infections / Intensive Care Units / Internet / Drug Utilization / Cross-infection / Medical Audit

Profilaxis antibiótica en cirugía otorrinolaringológica

Evidence Based Medicine / Clinical Trial / Prospective studies / Humans / Cochlear Implant / Laser Cataract Surgery / Antibiotic Prophylaxis / Clinical Sciences / Anti-Bacterial Agents / Adult / Retrospective Studies / Laser Therapy / Upper respiratory tract / Laser Cataract Surgery / Antibiotic Prophylaxis / Clinical Sciences / Anti-Bacterial Agents / Adult / Retrospective Studies / Laser Therapy / Upper respiratory tract

Profilaxis antibiótica en cirugía otorrinolaringológica

Evidence Based Medicine / Clinical Trial / Prospective studies / Humans / Cochlear Implant / Laser Cataract Surgery / Antibiotic Prophylaxis / Clinical Sciences / Anti-Bacterial Agents / Adult / Retrospective Studies / Laser Therapy / Upper respiratory tract / Laser Cataract Surgery / Antibiotic Prophylaxis / Clinical Sciences / Anti-Bacterial Agents / Adult / Retrospective Studies / Laser Therapy / Upper respiratory tract

Bacteremia Incidence in Pediatric Patients under Dental General Anesthesia

Risk assessment / Adolescent / Humans / Child / Female / Male / Antibiotic Prophylaxis / Mental Disorders / Incidence / General Anesthesia / Disabled children / Bacteremia / Tooth Extraction / Risk Assessment / Congenital Heart Disease / Male / Antibiotic Prophylaxis / Mental Disorders / Incidence / General Anesthesia / Disabled children / Bacteremia / Tooth Extraction / Risk Assessment / Congenital Heart Disease

Antimicrobial Drugs

Pharmacology / Microbiology / Pharmacy / Immunology / Antibiotic Prophylaxis / Antibiotics / Antifungals / Dental infections / Antibiotics / Antifungals / Dental infections

Usar rifampicina más pirazinamida en profilaxis antituberculosa no incrementa el riesgo de hepatotoxicidad grave en pacientes infectados por virus de la inmunodeficiencia humana: metaanálisis de ensayos clínicos aleatorizados y controlados

Medical Microbiology / Risk / Tuberculosis / Humans / Antibiotic Prophylaxis / Hiv Infection / Human immunodeficiency virus / Combination drug therapy / Isoniazid / Drug Induced Liver Injury / Pyrazinamide / Latent tuberculosis infection / Hiv Infection / Human immunodeficiency virus / Combination drug therapy / Isoniazid / Drug Induced Liver Injury / Pyrazinamide / Latent tuberculosis infection

Infecciones orales y endocarditis infecciosa

Humans / Oral health / Antibiotic Prophylaxis / Anti-Bacterial Agents / Infective Endocarditis / Mouth / Mastication / Oral Hygiene / Dental Care / Bacteremia / Medicina Clinica / Mouth / Mastication / Oral Hygiene / Dental Care / Bacteremia / Medicina Clinica

Single-incision laparoscopic transabdominal preperitoneal herniorrhaphy for recurrent inguinal hernias: preliminary surgical results

Treatment Outcome / Prospective studies / Humans / Female / Male / Antibiotic Prophylaxis / Length of Stay / Recurrence / Clinical Sciences / Aged / Middle Aged / Adult / Inguinal Hernia / Time Factors / Laparoscopy / Antibiotic Prophylaxis / Length of Stay / Recurrence / Clinical Sciences / Aged / Middle Aged / Adult / Inguinal Hernia / Time Factors / Laparoscopy
Copyright © 2017 DATOSPDF Inc.